Product Details
Simbrinza
Brinzolamide + Brimonidine Tartrate1% + 0.2%
Ophthalmic Suspension
10-mL Pack
DIN/PIN/NPN
02435411
Manufacturer
Novartis Pharma Canada Inc.
Formulary Listing Date
2015-10-29
Unit Price
50.6900
Amount MOH Pays
50.6900
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
S01EC54
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 466 | 1 year | As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with brinzolamide or brimonidine |
| 393 | Indefinite | For use as initial therapy in an urgent situation (e.g., patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective |